GRP
MDGL icon

Global Retirement Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Global Retirement Partners’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8K Buy
+63
New +$32.3K ﹤0.01% 2765
2025
Q4 		$47.8K Buy
82
+8
+11% +$4.09K ﹤0.01% 2379
2025
Q3 		$33.9K Buy
74
+51
+222% +$19K ﹤0.01% 2111
2025
Q2 		$6.96K Buy
+23
New +$6.85K ﹤0.01% 2766
2024
Q4 		$24.4K Buy
79
+7
+10% +$1.97K ﹤0.01% 1987
2024
Q3 		$15.3K Sell
72
-7
-9% -$1.79K ﹤0.01% 2124
2024
Q2 		$22.1K Buy
79
+57
+259% +$13.6K ﹤0.01% 1932
2024
Q1 		$5.88K Sell
22
-100
-82% -$23.6K ﹤0.01% 2332
2023
Q4 		$29.8K Buy
122
+100
+455% +$17.5K ﹤0.01% 1564
2023
Q3 		$2.99K Hold
22
– – ﹤0.01% 2380
2023
Q2 		$5.08K Hold
22
– – ﹤0.01% 2193
2023
Q1 		$6.71K Buy
+22
New +$6K ﹤0.01% 2069

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Global Retirement Partners's MDGL Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 63 shares worth $33.8K. The stake represents ﹤0.01% of the portfolio and ranks #2765 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in MDGL as recently as Q4 2025.

Global Retirement Partners first reported a position in MDGL in Q1 2023 and has held it in 12 quarters since. The position peaked at $47.8K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Global Retirement Partners held 63 shares of Madrigal Pharmaceuticals worth $33.8K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2765 holding.
  • Global Retirement Partners first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 12 quarters since.
  • Global Retirement Partners's Madrigal Pharmaceuticals position peaked at $47.8K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.